Sustained anti-osteoporotic action of risedronate compared to anti-RANKL antibody following discontinuation in ovariectomized mice

Toshinobu Omiya(The University of Tokyo), Sakae Tanaka(University of Tokyo Hospital), Masaki Inada(Tokyo University of Agriculture and Technology), Jun Hirose(Kumamoto University Hospital), Tsukasa Tominari(Tokyo University of Agriculture and Technology), Takeshi Miyamoto(Kumamoto Health Science University), Hisato Watanabe(The University of Tokyo), Yasunori Omata(The University of Tokyo)
Bone Reports
June 5, 2020
Cited by 12


Related Papers